\u010cL\u00c1NOK POKRA\u010cUJE POD REKLAMOU<\/p>\n
Niektor\u00e9 lieky m\u00f4\u017eu zmizn\u00fa\u0165 z lek\u00e1rn\u00ed aj prevent\u00edvne, ak sa pri nich objav\u00ed probl\u00e9m s kvalitou alebo bezpe\u010dnos\u0165ou. Tentoraz sa opatrenie t\u00fdka zn\u00e1meho lieku proti bolesti a z\u00e1palu. O pr\u00edpade informoval web \u0160\u00daKL<\/a> a stiahnutie sa vz\u0165ahuje na konkr\u00e9tnu \u0161ar\u017eu dostupn\u00fa na slovenskom trhu.<\/p>\n Stiahnutie konkr\u00e9tnej \u0161ar\u017ee<\/p>\n \u0160t\u00e1tny \u00fastav pre kontrolu lie\u010div upozornil na stiahnutie lieku<\/a> V*RAL 25 mg z trhu. Opatrenie sa t\u00fdka \u0161ar\u017ee ozna\u010denej \u010d\u00edslom K51013A s d\u00e1tumom exspir\u00e1cie okt\u00f3ber 2026. S\u0165ahovanie prebieha na \u00farovni distribu\u010dn\u00fdch spolo\u010dnost\u00ed, lek\u00e1rn\u00ed aj zdravotn\u00edckych zariaden\u00ed.<\/p>\n D\u00f4vodom je nes\u00falad v kvalite lieku. Pri kontrole sa zistila pr\u00edtomnos\u0165 ne\u010distoty nad povolen\u00fd limit. Ide o liek vo forme tabliet s obsahom diklofenaku sodn\u00e9ho, ktor\u00fd patr\u00ed medzi nesteroidn\u00e9 protiz\u00e1palov\u00e9 lieky.<\/p>\n Spolo\u010dnos\u0165 Herbacos Recordati s.r.o., ktor\u00e1 je dr\u017eite\u013eom registr\u00e1cie lieku, z\u00e1rove\u0148 vydala metodick\u00fd pokyn<\/a> k stiahnutiu predmetnej \u0161ar\u017ee. Distrib\u00fatori musia okam\u017eite zastavi\u0165 predaj dotknut\u00fdch balen\u00ed a vr\u00e1ti\u0165 z\u00e1soby sp\u00e4\u0165 do skladu spolo\u010dnosti v Pardubiciach najnesk\u00f4r do 26. j\u00fana 2026.<\/p>\n Na \u010do sa liek pou\u017e\u00edva<\/p>\n VE*AL 25 mg sa pou\u017e\u00edva pri kr\u00e1tkodobej lie\u010dbe bolesti, z\u00e1palu a opuchov. Pom\u00e1ha tie\u017e zni\u017eova\u0165 hor\u00fa\u010dku. Lek\u00e1ri ho predpisuj\u00fa napr\u00edklad pri bolestiach chrbta, bolestivej men\u0161tru\u00e1cii \u010di bolestiach hlavy.<\/p>\n Vyu\u017e\u00edva sa aj pri natiahnut\u00ed svalov, vyvrtnutiach, bolestiach k\u013abov alebo pri \u010fal\u0161\u00edch po\u00farazov\u00fdch stavoch. Liek v\u0161ak pod\u013ea odborn\u00fdch inform\u00e1ci\u00ed neodstra\u0148uje samotn\u00fa pr\u00ed\u010dinu z\u00e1palu, ale zmier\u0148uje jeho prejavy.<\/p>\n \u0160\u00daKL z\u00e1rove\u0148 uviedol, \u017ee lie\u010dba pacientov by nemala by\u0165 ohrozen\u00e1. Na trhu s\u00fa toti\u017e dostupn\u00e9 in\u00e9 \u0161ar\u017ee rovnak\u00e9ho lieku aj \u010fal\u0161ie pr\u00edpravky s rovnak\u00fdm lie\u010divom v rovnakej forme. Ak m\u00e1\u0161 doma balenie z dotknutej \u0161ar\u017ee, vhodn\u00fd postup ti odporu\u010d\u00ed lek\u00e1r alebo lek\u00e1rnik.<\/p>\n Pokyny pre lek\u00e1rne a distrib\u00fatorov<\/p>\n Lek\u00e1rne a zdravotn\u00edcke zariadenia musia vr\u00e1ti\u0165 nevyu\u017eit\u00e9 balenia distribu\u010dn\u00fdm spolo\u010dnostiam, od ktor\u00fdch liek nak\u00fapili. Term\u00edn na vr\u00e1tenie je stanoven\u00fd do 15. j\u00fana 2026. Distribu\u010dn\u00e9 firmy n\u00e1sledne vr\u00e1tia predmetn\u00fa \u0161ar\u017eu sp\u00e4\u0165 spolo\u010dnosti Herbacos Recordati. Kompenz\u00e1cia bude rie\u0161en\u00e1 formou dobropisov v r\u00e1mci dod\u00e1vate\u013esk\u00e9ho re\u0165azca.<\/p>\n V metodickom pokyne sa z\u00e1rove\u0148 uv\u00e1dza, \u017ee spolo\u010dnos\u0165 bude akceptova\u0165 vr\u00e1tenie dotknut\u00fdch balen\u00ed len do ur\u010den\u00fdch term\u00ednov. Stiahnutie sa t\u00fdka konkr\u00e9tne lieku VE*AL 25 mg, tbl ent 30\u00d725 mg v balen\u00ed blis.Al\/PVC.<\/p>\n Podozrenie na fal\u0161ovan\u00fd liek<\/p>\n \u0160\u00daKL aktu\u00e1lne rie\u0161i stiahnutie lieku VE*AL 25 mg, nejde v\u0161ak o prv\u00fd podobn\u00fd pr\u00edpad za posledn\u00e9 mesiace. O problematike bezpe\u010dnosti liekov sme informovali<\/a> u\u017e v minulosti, ke\u010f regula\u010dn\u00e9 org\u00e1ny upozornili na \u010fal\u0161ie rizikov\u00e9 pr\u00edpravky dostupn\u00e9 na slovenskom trhu.<\/p>\n V apr\u00edli sa objavilo upozornenie na mo\u017en\u00e9 fal\u0161ovan\u00e9 balenia lieku Dy*port 500 U. I\u0161lo o pr\u00e1\u0161ok na injek\u010dn\u00fd roztok so \u0161ar\u017eou P09903 a exspir\u00e1ciou 06\/2027. Problematick\u00e9 balenia boli v anglickom jazyku. Spolo\u010dnos\u0165 Ipsen Pharma z Franc\u00fazska potvrdila, \u017ee uveden\u00e1 \u0161ar\u017ea nepoch\u00e1dza z ich v\u00fdroby. P\u00f4vod lieku tak nebolo mo\u017en\u00e9 overi\u0165.<\/p>\n Dy*port obsahuje botul\u00ednov\u00fd tox\u00edn typu A a vyu\u017e\u00edva sa pri lie\u010dbe svalov\u00fdch k\u0155\u010dov, detskej mozgovej obrny, nadmern\u00e9ho potenia \u010di inkontinencie. Pod\u00e1va\u0165 ho m\u00f4\u017eu iba lek\u00e1ri s potrebnou odbornou praxou.<\/p>\n Stiahnutie lieku na akn\u00e9<\/p>\n \u0160\u00daKL z\u00e1rove\u0148 rie\u0161il aj stiahnutie<\/a> niektor\u00fdch balen\u00ed lieku Akne*ycin Plus ur\u010den\u00e9ho na lie\u010dbu akn\u00e9. Opatrenie sa t\u00fdkalo \u0161ar\u017e\u00ed 51316X2 a 541193. D\u00f4vodom bol nes\u00falad vo vzh\u013eade vn\u00fatorn\u00e9ho obalu. Aj v tomto pr\u00edpade v\u0161ak regula\u010dn\u00e9 org\u00e1ny upozornili, \u017ee ide o prevent\u00edvne opatrenie zameran\u00e9 na dodr\u017eiavanie kvalitat\u00edvnych \u0161tandardov.<\/p>\n \u0160\u00daKL v s\u00favislosti s predch\u00e1dzaj\u00facimi pr\u00edpadmi vyzval dr\u017eite\u013eov povolen\u00ed na zaobch\u00e1dzanie s liekmi, aby si d\u00f4sledne overovali dod\u00e1vate\u013eov a lieky nakupovali len od opr\u00e1vnen\u00fdch subjektov.<\/p>\n Pacienti by pod\u013ea odborn\u00edkov nemali meni\u0165 lie\u010dbu bez konzult\u00e1cie s lek\u00e1rom alebo lek\u00e1rnikom. Aj pri stiahnut\u00ed konkr\u00e9tnych \u0161ar\u017e\u00ed toti\u017e \u010dasto zost\u00e1vaj\u00fa dostupn\u00e9 alternat\u00edvne lieky s rovnak\u00fdm \u00fa\u010dinkom.<\/p>\n \n \u010c\u00edtaj viac z kateg\u00f3rie: Zo Slovenska<\/a>\n <\/p>\n \n \u010eakujeme, \u017ee \u010d\u00edta\u0161 Startitup. V pr\u00edpade, \u017ee m\u00e1\u0161 postreh alebo si na\u0161iel v \u010dl\u00e1nku chybu, nap\u00ed\u0161 n\u00e1m na redakcia@startitup.sk<\/a>.\n <\/p>\n Zdroje: sukl.sk<\/a>, sukl.sk<\/a>, startitup.sk<\/a>, startitup.sk<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"\u010cL\u00c1NOK POKRA\u010cUJE POD REKLAMOU Niektor\u00e9 lieky m\u00f4\u017eu zmizn\u00fa\u0165 z lek\u00e1rn\u00ed aj prevent\u00edvne, ak sa pri nich objav\u00ed probl\u00e9m…\n","protected":false},"author":2,"featured_media":81802,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[32],"tags":[34,37,3500,33,43,40,39,42,41,36,1029,29932,38,35],"class_list":["post-81801","post","type-post","status-publish","format-standard","has-post-thumbnail","category-spravy","tag-headlines","tag-hlavne-spravy","tag-liek","tag-news","tag-sk","tag-slovak","tag-slovakia","tag-slovencina","tag-slovensko","tag-spravy","tag-sukl","tag-sukl-stahuje","tag-titulky","tag-top-stories"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@sk\/116648081271466551","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/posts\/81801","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/comments?post=81801"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/posts\/81801\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/media\/81802"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/media?parent=81801"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/categories?post=81801"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/tags?post=81801"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}